Fox Jonathan C
Officer at Eidos Therapeutics, Inc.
- Sold, on record
- $7.3M
- Dollars the filings state
- Form 4 sales
- 21
- Latest Sep 17, 2020
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Eidos Therapeutics, Inc.Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Eidos Therapeutics, Inc.Plan not statedFeb 13, 2020 2020
Sold 10,000 shares at $54.00 ($540k)
Fox Jonathan C, Officer
Sold 2.3% of holdings ($23.1M position)418,625 shares left2x usual sizeFiling
- 2 Form 4 sale Eidos Therapeutics, Inc.Plan not statedMar 2, 2020 +18 days
Sold 10,000 shares at $51.57 ($516k)
Fox Jonathan C, Officer
Sold 2.4% of holdings ($21.6M position)408,625 shares left1.3x usual sizeFiling
- 3 Form 4 sale Eidos Therapeutics, Inc.Plan not statedApr 24, 2020 +53 days
Sold 5,000 shares at $50.00 ($250k)
Fox Jonathan C, Officer
Sold 1.2% of holdings ($20.4M position)403,625 shares left0.5x usual sizeFiling
- 4 Form 4 sale Eidos Therapeutics, Inc.Plan not statedMay 28, 2020 +34 days
Sold 5,000 shares at $50.00 ($250k)
Fox Jonathan C, Officer
Sold 1.2% of holdings ($20.2M position)398,625 shares left0.7x usual sizeFiling
- 5 Form 4 sale Eidos Therapeutics, Inc.Plan not statedJun 3, 2020 +6 days
Sold 5,000 shares at $50.00 ($250k)
Fox Jonathan C, Officer
Sold 1.3% of holdings ($19.8M position)391,585 shares left1x usual sizeFiling
- 6 Form 4 sale Eidos Therapeutics, Inc.Plan not statedJul 7, 2020 +34 days
Sold 5,000 shares at $50.00 ($250k)
Fox Jonathan C, Officer
Sold 1.3% of holdings ($19.6M position)387,673 shares left1x usual sizeFiling
- 7 Form 4 sale Eidos Therapeutics, Inc.Plan not statedSep 16, 2020 +71 days
Sold 4,233 shares at $50.13 ($212k)
Fox Jonathan C, Officer
Sold 1.1% of holdings ($19.4M position)383,440 shares left0.8x usual sizeFiling
- 8 Form 4 sale Eidos Therapeutics, Inc.Plan not statedSep 17, 2020 +1 day
Sold 5,767 shares at $50.16 ($289k)
Fox Jonathan C, Officer
Sold 1.5% of holdings ($19.2M position)377,673 shares left1.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (21)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 17, 2020 | Sep 18, 2020 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 5,767 | $289k | 1.5% | Plan not stated | SEC |
| Sep 16, 2020 | Sep 16, 2020 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 4,233 | $212k | 1.1% | Plan not stated | SEC |
| Jul 7, 2020 | Jul 9, 2020 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 5,000 | $250k | 1.3% | Plan not stated | SEC |
| Jun 3, 2020 | Jun 5, 2020 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 5,000 | $250k | 1.3% | Plan not stated | SEC |
| May 28, 2020 | Jun 1, 2020 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 5,000 | $250k | 1.2% | Plan not stated | SEC |
| Apr 24, 2020 | Apr 27, 2020 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 5,000 | $250k | 1.2% | Plan not stated | SEC |
| Mar 2, 2020 | Mar 4, 2020 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 10,000 | $516k | 2.4% | Plan not stated | SEC |
| Feb 13, 2020 | Feb 19, 2020 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 10,000 | $540k | 2.3% | Plan not stated | SEC |
| Jan 15, 2020 | Jan 16, 2020 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 10,000 | $550k | 2.3% | Plan not stated | SEC |
| Dec 4, 2019 | Dec 5, 2019 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 10,000 | $589k | 2.2% | Plan not stated | SEC |
| Nov 25, 2019 | Nov 27, 2019 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 10,000 | $565k | 2.2% | Plan not stated | SEC |
| Nov 21, 2019 | Nov 22, 2019 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 10,000 | $551k | 2.1% | Plan not stated | SEC |
| Nov 18, 2019 | Nov 19, 2019 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 15,000 | $730k | 3.1% | Unusual | SEC |
| Oct 15, 2019 | Oct 16, 2019 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 5,000 | $181k | 1.0% | Plan not stated | SEC |
| Sep 16, 2019 | Sep 18, 2019 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 5,000 | $229k | 1.0% | Plan not stated | SEC |
| Aug 15, 2019 | Aug 19, 2019 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 5,000 | $194k | 1.0% | Plan not stated | SEC |
| Jul 15, 2019 | Jul 17, 2019 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 15,000 | $601k | 2.9% | Unusual | SEC |
| May 30, 2019 | May 31, 2019 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 5,000 | $163k | 1.0% | Plan not stated | SEC |
| May 3, 2019 | May 6, 2019 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 5,000 | $125k | 0.9% | Plan not stated | SEC |
| May 1, 2019 | May 3, 2019 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 5,000 | $127k | 0.9% | Plan not stated | SEC |
| Apr 15, 2019 | Apr 16, 2019 | Eidos Therapeutics, Inc. | Officer | Form 4 sale | 5,000 | $116k | 0.9% | Plan not stated | SEC |